Loading...
A Pilot Pharmacologic Biomarker Study in HLA-Haploidentical Hematopoietic Cell Transplant Recipients
PURPOSE: Eleven patients diagnosed with various hematologic malignancies receiving an HLA-haploidentical hematopoietic cell transplant (HCT) participated in an ancillary biomarker trial. The goal of the trial was to evaluate potential pharmacologic biomarkers pertinent to the conditioning regimen (f...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
2013
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3786586/ https://ncbi.nlm.nih.gov/pubmed/23907443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2232-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|